Single answer
Is Aurinia Pharmaceuticals Inc (AUPH) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $1.40 or 39.91%
(In 16 weeks 2 days 23 hours 34 minutes and 45 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Aurinia Pharmaceuticals Inc is $15.50, which is $1.531 (10.96%) above the current price today's price.
Low target: $15.00 | High target: $16.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Aurinia Pharmaceuticals Inc a commercialstage biopharmaceutical company focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis It has a collaboration and license agreement with Otsuka Pharmaceutical Co Ltd The company is headquartered in Victoria Canada
Website: https://www.auriniapharma.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.15. Cash flow to debt ratio: 1.54. Net profit margin: 29.28%. Inflation risk score: low (0.15/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Aurinia Pharmaceuticals Inc is $18.9M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Aurinia Pharmaceuticals Inc, 2016-02-26 had a stock price of $2.11. If you invested back then, your return now would be a profit of $12.32 per share or 583.89%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.